CLINICAL_TRIALS
trial_result
· 2020-01-31
Clinical Trial Update: Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD) [Phase 2]
Summary
Phase 2 clinical trial update for iloperidone in addressing arousal symptoms in PTSD has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Post Traumatic Stress Disorder | Phase 2 | Status: TERMINATED | Results posted: 2020-01-31